We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.

Delisted

BDSI was delisted on the 22nd of March, 2022.

158 hedge funds and large institutions have $309M invested in BioDelivery Sciences International, Inc. in 2020 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 59 increasing their positions, 40 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

104% more call options, than puts

Call options by funds: $485K | Put options by funds: $238K

48% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 40

37% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 19

18% more capital invested

Capital invested by funds: $263M → $309M (+$46.4M)

3% more funds holding

Funds holding: 153158 (+5)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
158
Holders Change
+5
Holders Change %
+3.27%
% of All Funds
3.24%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
26
Increased
59
Reduced
40
Closed
19
Calls
$485K
Puts
$238K
Net Calls
+$247K
Net Calls Change
+$865K
Name Holding Trade Value Shares
Change
Change in
Stake
Los Angeles Capital Management
26
Los Angeles Capital Management
California
$2.92M +$597K +132,925 +25%
EP
27
Eversept Partners
New York
$2.54M +$2.07M +460,802 +376%
Assenagon Asset Management
28
Assenagon Asset Management
Luxembourg
$2.47M +$2.5M +555,542 +5,264%
MSL
29
Mackay Shields LLC
New York
$2.43M +$132K +29,400 +6%
Marshall Wace
30
Marshall Wace
United Kingdom
$2.43M +$2.5M +556,539 New
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$2.26M -$213K -47,363 -8%
DMK
32
David M. Knott
$2.2M
MAM
33
Martingale Asset Management
Massachusetts
$2.07M
AQR Capital Management
34
AQR Capital Management
Connecticut
$2.04M -$204K -45,289 -9%
CCM
35
Cadence Capital Management
Massachusetts
$1.83M +$456K +101,539 +32%
Dimensional Fund Advisors
36
Dimensional Fund Advisors
Texas
$1.81M +$713K +158,655 +62%
WG
37
Winton Group
United Kingdom
$1.73M +$563K +125,279 +46%
Wells Fargo
38
Wells Fargo
California
$1.72M +$424K +94,340 +31%
Russell Investments Group
39
Russell Investments Group
United Kingdom
$1.61M +$1.06M +234,832 +175%
EIM
40
Essex Investment Management
Massachusetts
$1.55M -$7.76K -1,727 -0.5%
Bank of New York Mellon
41
Bank of New York Mellon
New York
$1.51M +$76.6K +17,052 +5%
OAM
42
Oberweis Asset Management
Illinois
$1.45M +$889K +197,800 +148%
KCM
43
Kennedy Capital Management
Missouri
$1.28M -$1.52M -339,052 -54%
MF
44
Magnetar Financial
Illinois
$1.26M +$1.3M +288,895 New
Citadel Advisors
45
Citadel Advisors
Florida
$1.13M +$150K +33,364 +15%
CAM
46
ClariVest Asset Management
California
$1.12M -$329K -73,312 -22%
Bessemer Group
47
Bessemer Group
New Jersey
$1.08M
Barclays
48
Barclays
United Kingdom
$937K +$962K +214,027 +23,188%
BC
49
Brinker Capital
Pennsylvania
$922K +$18K +4,014 +2%
California Public Employees Retirement System
50
California Public Employees Retirement System
California
$888K +$58.3K +12,968 +7%

BDSI Hedge Fund Activity: Q2 2020 in Review

158 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q2 2020, worth a combined $309M — up 18% from $263M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new BDSI positions and 19 closed out — a net gain of 7 holders — while 59 added to existing stakes and 40 trimmed.

The largest buyer was Vanguard Group, adding an estimated $3.72M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $6.21M sold.

  • 158 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q2 2020, up from 153 in Q1 2020.
  • Funds reported $309M of BioDelivery Sciences International, Inc. stock for Q2 2020, up 18% quarter-over-quarter.
  • 26 funds opened new BioDelivery Sciences International, Inc. positions in Q2 2020 and 19 closed out, a net change of +7 holders.
  • The largest BioDelivery Sciences International, Inc. buyer in Q2 2020 was Vanguard Group, an estimated $3.72M added.
  • The largest BioDelivery Sciences International, Inc. seller in Q2 2020 was Baker Bros. Advisors, an estimated $6.21M sold.

Based on aggregated 13F filings for Q2 2020.